Cutaneous manifestations related to the COVID-19 pandemic: a review article

被引:6
|
作者
Molaee, Hamideh [1 ]
Allahyari, Fakhri [2 ]
Emadi, Seyed Naser [3 ]
Radfar, Shokofeh [5 ]
Razavi, Zahra [4 ]
机构
[1] Baqiyatallah Univ Med Sci, Trauma Res Ctr, Tehran, Iran
[2] Baqyiatallah Univ Med Sci, Neurosci Res Ctr, Tehran, Iran
[3] Univ Tehran Med Sci, Skin Res Ctr, Razi & Imam Khomeini Hosp, Tehran 17166, Iran
[4] Univ Tehran Med Sci, Dermatol Dept, Razi Hosp, Tehran, Iran
[5] Baqiyatallah Univ Med Sci, Behav Sci Res Ctr, Lifestyle Inst, Tehran 17166, Iran
关键词
COVID-19; skin manifestation; maculopapular rash; cutaneous drug reactions; traumatic skin condition; psychocutaneous disorders; autoimmune skin disorders; inflammatory skin disorders;
D O I
10.1080/15569527.2021.1919138
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background Skin lesions are either caused by COVID-19 disease or they can be due to other driving forces related to the COVID-19 pandemic. Aim Considering the fact that the reported data in different articles for the type and prevalence of skin manifestations related to the COVID-19 pandemic are inconsistent, we have described the mechanism and type of skin lesions related to the COVID-19 pandemic. Methods In this review article, we have searched the Medline database (PubMed) for the combination of the following key terms "Dermatological Manifestation", "cutaneous Manifestation", "Skin Manifestation", "COVID-19", "SARS-CoV-2". Results The prevalence of skin manifestations related to COVID-19 ranged from 0.2% to 20%. The majority of these skin lesions are maculopapular eruptions. The skin presentations related to the COVID-19 pandemic are described below. Traumatic skin conditions such as dermatitis in individuals, especially those with allergies, might initiate secondary to over-washing or rinsing with inappropriate detergents. Also, inappropriate use of personal protective equipment (mask-gloves-shield) can trigger skin lesions on the face and hands or aggravate the lesions of acne, seborrhoeic dermatitis, eczema, etc. Furthermore, cutaneous adverse drug reactions may occur during hospitalization or outpatient treatment of COVID-19 patients. Also, psychocutaneous disorders due to acute stress can trigger or deteriorate several skin manifestations. Moreover, COVID-19 prevalence and course may be changed in patients with autoimmune or chronic inflammatory underlying skin disorders such as psoriasis, lupus erythematosus, pemphigus, scleroderma who are on immunosuppressive or biological medications to control their disorders. Conclusion Due to the various dimensions of skin organ involvement and the large population affected, long-term skin conditions following this pandemic can be a lot more problematic than it appears. Serious preventive measures and medical supports are necessary to avoid skin disorders from becoming permanent or even chronic.
引用
收藏
页码:168 / 174
页数:7
相关论文
共 50 条
  • [41] Management of Pemphigus in COVID-19 Pandemic Era; a Review Article
    Abdollahimajd, Fahimeh
    Shahidi-Dadras, Mohammad
    Robati, Reza M.
    Dadkhahfar, Sahar
    [J]. ARCHIVES OF ACADEMIC EMERGENCY MEDICINE, 2020, 8 (01)
  • [42] COVID toes and other cutaneous manifestations of COVID-19
    Rose-Sauld, Sara
    Dua, Anahita
    [J]. JOURNAL OF WOUND CARE, 2020, 29 (09) : 486 - 487
  • [43] Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue
    Marzano, A. V.
    Cassano, N.
    Genovese, G.
    Moltrasio, C.
    Vena, G. A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (03) : 431 - 442
  • [44] Cutaneous manifestations of COVID-19: Report of three cases and a review of literature
    Sachdeva, Muskaan
    Gianotti, Raffaele
    Shah, Monica
    Bradanini, Lucia
    Tosi, Diego
    Veraldi, Stefano
    Ziv, Michael
    Leshem, Eyal
    Dodiuk-Gad, Roni P.
    [J]. JOURNAL OF DERMATOLOGICAL SCIENCE, 2020, 98 (02) : 75 - 81
  • [45] Cutaneous manifestations of the Coronavirus Disease 2019 (COVID-19): A brief review
    Tang, Keyun
    Wang, Yuanzhuo
    Zhang, Hanlin
    Zheng, Qingyue
    Fang, Rouyu
    Sun, Qiuning
    [J]. DERMATOLOGIC THERAPY, 2020, 33 (04)
  • [46] Big data and cutaneous manifestations of COVID-19
    Grant-Kels, Jane M.
    Sloan, Brett
    Kantor, Jonathan
    Elston, Dirk M.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (02) : 365 - 366
  • [47] Cutaneous manifestations in COVID-19: current state
    El Jazouly, Madiha
    Chahboun, Fatim Zahra
    Chiheb, Soumiya
    [J]. PAN AFRICAN MEDICAL JOURNAL, 2020, 35
  • [48] Cutaneous Manifestations of COVID-19 in the Inpatient Setting
    Do, Mytrang H.
    Stewart, Claire R.
    Harp, Joanna
    [J]. DERMATOLOGIC CLINICS, 2021, 39 (04) : 521 - 532
  • [49] Cutaneous Manifestations of COVID-19 in Critical Care
    Swoboda, Laura
    [J]. AACN ADVANCED CRITICAL CARE, 2022, 33 (02) : 186 - 195
  • [50] Cutaneous manifestations in COVID-19: a new contribution
    Estebanez, A.
    Perez-Santiago, L.
    Silva, E.
    Guillen-Climent, S.
    Garcia-Vazquez, A.
    Ramon, M. D.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (06) : E250 - E251